NeuroInsights, May 2010
by Indication (2009)
3-2: FDA Pharmaceutical Approval Process
3-3: Big Pharma neuropharmaceutical revenues
3-4: Neuropharmaceutical Partnering and Licensing Deals 2004-Q1 2010
3-5: Clinical Trials for Alzheimer
Espicom Business Intelligence Ltd, Oct 2009, Pages: 218
.
The future of the pharmaceuticalindustry lies with biotechnology. Biotech drugs account for around 10-15% of the current pharmaceutical market, and the sector is outperforming the market as a whole in terms
Global Industry Analysts, Inc., Oct 2008, Pages: 490
of Mushrooms II-54
HiMedia Laboratories Forges Distribution Deal with VWR
International II-54
Teva Signs Collaboration Agreement